Anticholinergic antiparkinsonian drugs in psychiatry.
In this article the treatment of drug-induced extrapyramidal disorders is briefly reviewed. Anticholinergic antiparkinsonian drugs are discussed with emphasis on the extent of their usage; the potential for abuse, causing confusion, and impairing cognition; and their effect on neuroleptic drug levels and on tardive dyskinesia. Practical guidance for their use is included.
Lucy Baldwin Hospital, Stourport-on-Severn, Hereford.
J A
JA
Boodhoo
M
M
Sandler
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002985:Clinical Protocols; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D006801:Humans; D011788:Quality of Life
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents